|
3704
|
(S)-ErSO
|
Inactive enantiomer of ErSO |
€180.00
|
|
4122
|
C101248
|
First potent and selective THIK-1 inhibitor |
€120.00
|
|
3906
|
CA77.1
|
Orally bioavailable and brain-penetrant CMA activator |
€90.00
|
|
3570
|
CD38 inhibitor compound 78c
|
Potent, specific, reversible, and uncompetitive inhibitor of CD38 |
€140.00
|
|
3891
|
Clioquinol
|
MMP14/CLK-1 inhibitor; Metal chelator |
€50.00
|
|
4329
|
Etimizol
|
CK2 ligand; Cognitive enhancer; Nootropic drug |
Recently added
|
€130.00
|
|
3612
|
GAPDH inhibitor compound F8
|
Covalent GAPDH inhibitor |
€120.00
|
|
4311
|
GSK-3β inhibitor 12
|
GSK-3β inhibitor |
€90.00
|
|
4300
|
Ibetazol
|
Inhibitor of Importin β1 |
€110.00
|
|
4201
|
Iclepertin
|
Potent, selective and orally active GlyT-1 inhibitor |
€240.00
|
|
3666
|
L-DOPA
|
Dopamine precursor |
€50.00
|
|
3909
|
NFATc1 inhibitor A04
|
Potent RANKL-induced osteoclastogenesis inhibitor |
€90.00
|
|
3572
|
Nicotinamide riboside chloride
|
NAD+ precursor |
€60.00
|
|
4308
|
Nurr1 agonist 7
|
Nurr1 agonist |
€120.00
|
|
4310
|
Nurr1 agonist 8
|
Nurr1 agonist |
€120.00
|
|
4020
|
O4I4
|
Metabolically stable next-generation endogenous Oct4 inducer |
€90.00
|
|
4203
|
Pramiracetam
|
Nootropic drug |
€70.00
|
|
4249
|
Salubrinal
|
Selective eIF2α dephosphorylation inhibitor |
€110.00
|
|
4184
|
SLU-PP-332
|
Pan ERRα/β/γ agonist |
€90.00
|
|
1470
|
Tenilsetam
|
Alzheimer's disease therapeutic |
€65.00
|
|
4105
|
UNC3474 maleate
|
53BP1 antagonist |
€160.00
|
|
3889
|
Vinpocetine
|
Brain-penetrant PDE/IKK inhibitor; Na+ channel blocker |
€50.00
|
|
4307
|
Zagociguat
|
First potent brain-penetrant sGC stimulator |
€220.00
|